June 2009 Volume 12 Number 2, pp 105 - 208
---------------------------------------------------------------------
Prostate Cancer and Prostatic Diseases covers all aspects of
prostatic diseases, in particular prostate cancer. The journal is of
interest to surgeons, oncologists, clinicians, and researchers involved
in disease of the prostate. It publishes original research articles,
reviews, topical comments, and critical appraisal of scientific
meetings. Cant access full-text articles from this alert?
Visit
http://links.ealert.nature.com/ctt?kn=2&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
to let your librarian know you want full-text access from your desktop.
---------------------------------------------------------------------
Articles for Prostate Cancer and Prostatic Diseases are published
online ahead of print through Advance Online Publication (AOP),
meaning that the latest research reaches you in the timeliest way
possible. Check http://links.ealert.nature.com/ctt?kn=10&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
each week to make sure that you are not left behind.
----------------------
EDITORIAL
----------------------
Report from London
R Kirby
http://links.ealert.nature.com/ctt?kn=45&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
----------------------
RESEARCH HIGHLIGHTS
----------------------
Prostate News
http://links.ealert.nature.com/ctt?kn=53&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
----------------------
REVIEWS
----------------------
Exercise therapy across the prostate cancer continuum
J Antonelli, S J Freedland and L W Jones
Abstract: http://links.ealert.nature.com/ctt?kn=8&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=24&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Diagnostic evaluation of PSA recurrence and review of hormonal management
after radical prostatectomy
H Van Poppel, S Joniau, B Van Cleynenbreugel, F M Mottaghy and R Oyen
Abstract: http://links.ealert.nature.com/ctt?kn=75&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=87&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Salvage HIFU for recurrent prostate cancer after radiotherapy
V Chalasani, C H Martinez, D Lim and J Chin
Abstract: http://links.ealert.nature.com/ctt?kn=101&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=60&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
5[alpha]-Reductase inhibitor treatment of prostatic diseases: background
and practical implications
J Dorsam and J Altwein
Abstract: http://links.ealert.nature.com/ctt?kn=58&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=102&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Diagnostic accuracy of extended biopsies for the staging of microfocal
prostate cancers in autopsy specimen
N B Delongchamps, G de la Roza, V Chandan, R Jones, G Threatte,
M Jumbelic and G P Haas
Abstract: http://links.ealert.nature.com/ctt?kn=31&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=115&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Biopsy tissue microarray study of Ki-67 expression in untreated, localized
prostate cancer managed by active surveillance
S Jhavar, J Bartlett, G Kovacs, C Corbishley, D Dearnaley, R Eeles, V Khoo,
R Huddart, A Horwich, A Thompson, A Norman, D Brewer, C S Cooper and C Parker
Abstract: http://links.ealert.nature.com/ctt?kn=86&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=52&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
The patients less than 50 years: is there a need to lower the PSA cutoff
point?
I A Hekal
Abstract: http://links.ealert.nature.com/ctt?kn=69&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=73&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Efficacy and safety of dutasteride, tamsulosin and their combination in a
subpopulation of the CombAT study: 2-year results in Asian men with
moderate-to-severe BPH
B-H Chung, C G Roehrborn, P Siami, K Major-Walker, B B Morrill, T H Wilson
and F Montorsi
Abstract: http://links.ealert.nature.com/ctt?kn=39&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=65&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Insulin and free oestradiol are independent risk factors for benign
prostatic hyperplasia
J Hammarsten, J-E Damber, M Karlsson, T Knutson, O Ljunggren, C Ohlsson,
R Peeker, U Smith and D Mellstrom
Abstract: http://links.ealert.nature.com/ctt?kn=63&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=36&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Specific targeting of prostate cancer cells in vitro by the suicide
gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil,
under the control of prostate-specific membrane antigen promoter//enhancer
F J Zhao, S Zhang, Z M Yu, S J Xia and H Li
Abstract: http://links.ealert.nature.com/ctt?kn=121&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=116&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Impact of nerve sparing on surgical margins and biochemical recurrence:
results from the SEARCH database
J L Nelles, S J Freedland, J C Presti, M K Terris, W J Aronson, C L Amling
and C J Kane
Abstract: http://links.ealert.nature.com/ctt?kn=111&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=125&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome
and interstitial cystitis: a management strategy for urologic chronic pelvic
pain syndromes
D A Shoskes, J C Nickel, R R Rackley and M A Pontari
Abstract: http://links.ealert.nature.com/ctt?kn=93&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=119&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
An oncogenic role for the multiple endocrine neoplasia type 1 gene in
prostate cancer
P L Paris, S Sridharan, A B Hittelman, Y Kobayashi, S Perner, G Huang,
J Simko, P Carroll, M A Rubin and C Collins
Abstract: http://links.ealert.nature.com/ctt?kn=104&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=50&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Association of FGFR4 genetic polymorphisms with prostate cancer risk and
prognosis
L M FitzGerald, E Karlins, D M Karyadi, E M Kwon, J S Koopmeiners,
J L Stanford and E A Ostrander
Abstract: http://links.ealert.nature.com/ctt?kn=33&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=27&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Reduced muscle strength and functional performance in men with prostate
cancer undergoing androgen suppression: a comprehensive cross-sectional
investigation
D A Galvao, D R Taaffe, N Spry, D Joseph, D Turner and R U Newton
Abstract: http://links.ealert.nature.com/ctt?kn=106&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=32&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Side-specific factors associated with extracapsular extension and seminal
vesicular invasion in men undergoing open radical retropubic prostatectomy
A Sankin, B Tareen and H Lepor
Abstract: http://links.ealert.nature.com/ctt?kn=26&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=41&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
---------------------------------------------------------------------
Why submit your paper to Prostate Cancer and Prostatic Diseases?
Over 47,000 recipients will receive via e-mail a copy of the table of
contents for the issue in which your article is published. There are
an average of 30,000 page views across the Prostate Cancer and
Prostatic Diseases web site per month.
On average authors receive a first decision on their paper within 35
working days.
Visit
http://links.ealert.nature.com/ctt?kn=88&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=12&m=32913662&r=MTc2ODQ1OTU4MwS2&b=2&j=NDk0Mzk4NDcS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
